Deutsche Bank’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding FRTX
BI
SCM
FI
PAM
Deutsche Bank's FRTX Position: Q2 2019 in Review
Deutsche Bank sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q2 2019, closing a stake of 721 shares — an estimated $272K sold.
Deutsche Bank first reported a position in FRTX in Q2 2013 and held it in 18 quarters. The position peaked at $569K in Q4 2013. 22 funds tracked by Wall St. Rank hold FRTX as of Q2 2019.
- Deutsche Bank reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
- Deutsche Bank sold 721 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $272K.
- Deutsche Bank first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 18 quarters.
- Deutsche Bank's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $569K in Q4 2013.
- 22 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q2 2019.
Based on Deutsche Bank's 13F filing for Q2 2019, filed 14 Aug 2019.